These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28739507)

  • 1. Neuroactive steroids and diabetic complications in the nervous system.
    Giatti S; Mastrangelo R; D'Antonio M; Pesaresi M; Romano S; Diviccaro S; Caruso D; Mitro N; Melcangi RC
    Front Neuroendocrinol; 2018 Jan; 48():58-69. PubMed ID: 28739507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats.
    Pesaresi M; Maschi O; Giatti S; Garcia-Segura LM; Caruso D; Melcangi RC
    Horm Behav; 2010 Jan; 57(1):46-55. PubMed ID: 19422828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features.
    Pesaresi M; Giatti S; Spezzano R; Romano S; Diviccaro S; Borsello T; Mitro N; Caruso D; Garcia-Segura LM; Melcangi RC
    Biol Sex Differ; 2018 Jan; 9(1):6. PubMed ID: 29351809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
    Mitro N; Cermenati G; Brioschi E; Abbiati F; Audano M; Giatti S; Crestani M; De Fabiani E; Azcoitia I; Garcia-Segura LM; Caruso D; Melcangi RC
    J Steroid Biochem Mol Biol; 2014 Sep; 143():115-21. PubMed ID: 24607810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus.
    Giatti S; Diviccaro S; Melcangi RC
    Cell Mol Neurobiol; 2019 May; 39(4):493-502. PubMed ID: 30109515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: a correlation with the levels of neuroactive steroids in the sciatic nerve.
    Pesaresi M; Giatti S; Cavaletti G; Abbiati F; Calabrese D; Bianchi R; Caruso D; Garcia-Segura LM; Melcangi RC
    Exp Neurol; 2011 Apr; 228(2):215-21. PubMed ID: 21241692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiopathological Role of Neuroactive Steroids in the Peripheral Nervous System.
    Falvo E; Diviccaro S; Melcangi RC; Giatti S
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy.
    Pesaresi M; Giatti S; Cavaletti G; Abbiati F; Calabrese D; Lombardi R; Bianchi R; Lauria G; Caruso D; Garcia-Segura LM; Melcangi RC
    Neuroscience; 2011 Dec; 199():401-9. PubMed ID: 21945035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
    Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
    Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroactive steroids and peripheral neuropathy.
    Roglio I; Giatti S; Pesaresi M; Bianchi R; Cavaletti G; Lauria G; Garcia-Segura LM; Melcangi RC
    Brain Res Rev; 2008 Mar; 57(2):460-9. PubMed ID: 17543391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy.
    Cermenati G; Giatti S; Cavaletti G; Bianchi R; Maschi O; Pesaresi M; Abbiati F; Volonterio A; Saez E; Caruso D; Melcangi RC; Mitro N
    J Neurosci; 2010 Sep; 30(36):11896-901. PubMed ID: 20826654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
    Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR and TSPO as new therapeutic targets to increase the levels of neuroactive steroids in the central nervous system of diabetic animals.
    Mitro N; Cermenati G; Giatti S; Abbiati F; Pesaresi M; Calabrese D; Garcia-Segura LM; Caruso D; Melcangi RC
    Neurochem Int; 2012 May; 60(6):616-21. PubMed ID: 22406419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats.
    Caruso D; Pesaresi M; Maschi O; Giatti S; Garcia-Segura LM; Melcangi RC
    J Neuroendocrinol; 2010 Nov; 22(11):1137-47. PubMed ID: 20819120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
    Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
    Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.
    Melcangi RC; Giatti S; Calabrese D; Pesaresi M; Cermenati G; Mitro N; Viviani B; Garcia-Segura LM; Caruso D
    Prog Neurobiol; 2014 Feb; 113():56-69. PubMed ID: 23958466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroactive steroids, neurosteroidogenesis and sex.
    Giatti S; Garcia-Segura LM; Barreto GE; Melcangi RC
    Prog Neurobiol; 2019 May; 176():1-17. PubMed ID: 29981391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes.
    Veiga S; Leonelli E; Beelke M; Garcia-Segura LM; Melcangi RC
    Neurosci Lett; 2006 Jul; 402(1-2):150-3. PubMed ID: 16626861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroactive steroids and seizure susceptibility.
    Beyenburg S; Stoffel-Wagner B; Bauer J; Watzka M; Blümcke I; Bidlingmaier F; Elger CE
    Epilepsy Res; 2001 May; 44(2-3):141-53. PubMed ID: 11325570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
    Melcangi RC; Giatti S; Garcia-Segura LM
    Neurosci Biobehav Rev; 2016 Aug; 67():25-40. PubMed ID: 26657814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.